Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEREBRAIN for Cognitive Impairment in Frailty Patients
NCT06200883Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Sep 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Cerebrain in Mild Cognitive Impairment (MCI), sponsored by University of Naples Federico II. Started Sep 2022; status: completed.
02
Drugs
Cerebrain
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT06200883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200883.